ClinicalTrials.Veeva

Menu

The Validity of Kleinhauer Betke in Women With Known Hemoglobinopathy for Fetal-maternal Hemorrhage

H

Hillel Yaffe Medical Center

Status

Completed

Conditions

Fetal-Maternal Hemorrhage

Treatments

Diagnostic Test: Blood test

Study type

Interventional

Funder types

Other

Identifiers

NCT03591640
HYMC-0057-18

Details and patient eligibility

About

The aim of this study is to determine the validity of Kleinhauer Betke in women with known hemoglobinopathy for fetal-maternal hemorrhage.

Enrollment

27 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant with singleton fetus
  • Gestational age 34-42
  • With or without known hemoglobinopathy

Exclusion criteria

  • Known risk factor for fetal maternal hemorrhage

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

27 participants in 2 patient groups

Pregnant with hemoglobinopathy
Active Comparator group
Description:
Standard of care with blood test before active labor
Treatment:
Diagnostic Test: Blood test
Pregnant without known hemoglobinopathy
Active Comparator group
Description:
Standard of care with blood test before active labor
Treatment:
Diagnostic Test: Blood test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems